Bay City Capital Fund IV, L.P.

USReporting entityDirector

Insider

Bay City Capital Fund IV, L.P.

USReporting entityDirector

Transactions

Issuers

Buys / Sells

16/3

Last tx

11 Mar 2010

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
NEORX CORP	4,395,356	reported	16 Aug 2007	tx 12+5,166
MAP Pharmaceuticals, Inc.	2,007,163	reported	11 Mar 2010	tx 8+2,347,077−2,510,521
EnteroMedics Inc	57,106	reported	24 Apr 2008	tx 4+71,000

Recent transactions

Date	Type	Issuer	Qty	Price
09 Mar 2010	SALE	MAP Pharmaceuticals, Inc.	151,424	15.50 USD
10 Mar 2010	SALE	MAP Pharmaceuticals, Inc.	134,190	16.03 USD
11 Mar 2010	SALE	MAP Pharmaceuticals, Inc.	54,300	16.06 USD
24 Apr 2008	PURCHASE	EnteroMedics Inc	48,945	4.50 USD
24 Apr 2008	PURCHASE	EnteroMedics Inc	1,055	4.50 USD

InsiderLens aggregates public information issued by financial regulators (SEC, AMF, FCA, BaFin, AFM, FI, ASX). The service constitutes neither investment advice nor a recommendation to buy or sell. Past performance is no guarantee of future results. Investing in financial instruments carries the risk of capital loss.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
NEORX CORP	4,395,356	reported	16 Aug 2007	tx 12+5,166
MAP Pharmaceuticals, Inc.	2,007,163	reported	11 Mar 2010	tx 8+2,347,077−2,510,521
EnteroMedics Inc	57,106	reported	24 Apr 2008	tx 4+71,000

Recent transactions

Date	Type	Issuer	Qty	Price
09 Mar 2010	SALE	MAP Pharmaceuticals, Inc.	151,424	15.50 USD
10 Mar 2010	SALE	MAP Pharmaceuticals, Inc.	134,190	16.03 USD
11 Mar 2010	SALE	MAP Pharmaceuticals, Inc.	54,300	16.06 USD
24 Apr 2008	PURCHASE	EnteroMedics Inc	48,945	4.50 USD
24 Apr 2008	PURCHASE	EnteroMedics Inc	1,055	4.50 USD